These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9024384)

  • 1. Gene analysis in delta 4-3-oxosteroid 5 beta-reductase deficiency.
    Sumazaki R; Nakamura N; Shoda J; Kurosawa T; Tohma M
    Lancet; 1997 Feb; 349(9048):329. PubMed ID: 9024384
    [No Abstract]   [Full Text] [Related]  

  • 2. SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect.
    Gonzales E; Cresteil D; Baussan C; Dabadie A; Gerhardt MF; Jacquemin E
    J Hepatol; 2004 Apr; 40(4):716-8. PubMed ID: 15030995
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy.
    Lemonde HA; Custard EJ; Bouquet J; Duran M; Overmars H; Scambler PJ; Clayton PT
    Gut; 2003 Oct; 52(10):1494-9. PubMed ID: 12970144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delta 4-3-oxosteroid 5 beta-reductase deficiency causing neonatal liver failure and hemochromatosis.
    Shneider BL; Setchell KD; Whitington PF; Neilson KA; Suchy FJ
    J Pediatr; 1994 Feb; 124(2):234-8. PubMed ID: 8301429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing primary from secondary Δ(4) -3-oxosteroid 5β-reductase (SRD5B1, AKR1D1) deficiency by urinary steroid analysis.
    Yanagi T; Mizuochi T; Homma K; Ueki I; Seki Y; Hasegawa T; Takei H; Nittono H; Kurosawa T; Matsuishi T; Kimura A
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):346-51. PubMed ID: 25154774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta 4-3-oxosteroid 5 beta-reductase deficiency and neonatal hemochromatosis.
    Clayton PT
    J Pediatr; 1994 Nov; 125(5 Pt 1):845-6. PubMed ID: 7965448
    [No Abstract]   [Full Text] [Related]  

  • 7. Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid.
    Clayton PT; Mills KA; Johnson AW; Barabino A; Marazzi MG
    Gut; 1996 Apr; 38(4):623-8. PubMed ID: 8707100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis.
    Setchell KD; Suchy FJ; Welsh MB; Zimmer-Nechemias L; Heubi J; Balistreri WF
    J Clin Invest; 1988 Dec; 82(6):2148-57. PubMed ID: 3198770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency.
    Ueki I; Kimura A; Chen HL; Yorifuji T; Mori J; Itoh S; Maruyama K; Ishige T; Takei H; Nittono H; Kurosawa T; Kage M; Matsuishi T
    J Gastroenterol Hepatol; 2009 May; 24(5):776-85. PubMed ID: 19175828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary ∆4-3-oxosteroid 5β-reductase deficiency: two cases in China.
    Zhao J; Fang LJ; Setchell KD; Chen R; Li LT; Wang JS
    World J Gastroenterol; 2012 Dec; 18(47):7113-7. PubMed ID: 23323017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal bile acid metabolism and neonatal hemochromatosis: a subset with poor prognosis.
    Siafakas CG; Jonas MM; Perez-Atayde AR
    J Pediatr Gastroenterol Nutr; 1997 Sep; 25(3):321-6. PubMed ID: 9285385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delta 4-3-oxosteroid 5 beta-reductase deficiency].
    Kondo KH; Kai MH; Setoguchi T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):282-4. PubMed ID: 9645062
    [No Abstract]   [Full Text] [Related]  

  • 13. [Congenital disorders of the bile acid metabolism (3 beta-hydroxy-delta 5-steroid dehydrogenase/isomerase deficiency, delta 4-3-oxosteroid 5 beta-reductase deficiency, cerebrotendinous xanthomatosis, and peroxisomal disorders].
    Kondo KH; Maeda Y; Setoguchi T
    Ryoikibetsu Shokogun Shirizu; 1995; (8):362-6. PubMed ID: 8581653
    [No Abstract]   [Full Text] [Related]  

  • 14. Resolution of liver biopsy alterations in three siblings with bile acid treatment of an inborn error of bile acid metabolism (delta 4-3-oxosteroid 5 beta-reductase deficiency).
    Daugherty CC; Setchell KD; Heubi JE; Balistreri WF
    Hepatology; 1993 Nov; 18(5):1096-101. PubMed ID: 8225213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Δ4-3-oxosteroid-5β-reductase deficiency: Responses to oral bile acid therapy and long-term outcomes.
    Zhang MH; Setchell KD; Zhao J; Gong JY; Lu Y; Wang JS
    World J Gastroenterol; 2019 Feb; 25(7):859-869. PubMed ID: 30809085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent AKR1D1 c.580-13T>A Variant: A Cause of Δ
    Zhao J; Qiu YL; Wang L; Li ZD; Xie XB; Lu Y; Setchell KDR; Cheng Y; Xing QH; Wang JS
    J Mol Diagn; 2023 Apr; 25(4):227-233. PubMed ID: 36739965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosinemia type I-like disease: a possible manifestation of 3-oxo-delta 4-steroid 5 beta-reductase deficiency.
    Kimura A; Endo F; Kagimoto S; Inoue T; Suzuki M; Kurosawa T; Tohma M; Fujisawa T; Kato H
    Acta Paediatr Jpn; 1998 Jun; 40(3):211-7. PubMed ID: 9695292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy.
    Gonzales E; Gerhardt MF; Fabre M; Setchell KD; Davit-Spraul A; Vincent I; Heubi JE; Bernard O; Jacquemin E
    Gastroenterology; 2009 Oct; 137(4):1310-1320.e1-3. PubMed ID: 19622360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC-ESI-MS/MS measurement of urinary bile acids.
    Muto A; Takei H; Unno A; Murai T; Kurosawa T; Ogawa S; Iida T; Ikegawa S; Mori J; Ohtake A; Hoshina T; Mizuochi T; Kimura A; Hofmann AF; Hagey LR; Nittono H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():24-31. PubMed ID: 22695323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency.
    Selzer RR; Rosenblatt DS; Laxova R; Hogan K
    N Engl J Med; 2003 Jul; 349(1):45-50. PubMed ID: 12840091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.